Sulfasalazine: a risk factor for severe COVID-19?

Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19

(2022) Ilona Nln et al.   Translational Research

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

(2021) Hannah Bower et al.   ANNALS OF THE RHEUMATIC DISEASES

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

(2021) Fanny Onodi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

(2021) Paul Bastard et al.   Science Immunology

Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters

(2021) Katarzyna M. Grzes et al.   IMMUNITY

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

(2020) Erica J. Brenner et al.   GASTROENTEROLOGY

Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case–control study in Asia

(2017) Tsai-Ling Liao et al.   BMJ Open